Discount codes available for IPKat readers interested in copyright or in pharma law

It's conference season also for Kats
The IPKat is happy to remind readers about two forthcoming events, devoted to copyright law and to competition law in the pharma sector, respectively.

If you are interested in copyright law and wish to discuss what has happened over the past few (eventful) months, then you may want to check details of the annual International Copyright Law conference that is taking place in London on 27 and 28 November 2018. The agenda of this event includes topics ranging from EU copyright and WIPO developments to Brexit and everything in-between. The other good news is that IPKat readers enjoy a 15% discount in the registration fee. Just click here to register and use the VIP code FKW82865IPKE2.

IPKat readers enjoy at 15% discount also for another event, devoted to discussing competition law aspects in the pharmaceutical sector and taking place in Brussels on 4 December 2018. The agenda of Competition Law in the Pharmaceutical Sector features speakers from the European Commission and national regulators, as well as in-house counsel and lawyers from across the industry. To register and claim the 15% discount on the registration fee, our readers just need to click here and use the VIP code FKW82867IPKE2.
Discount codes available for IPKat readers interested in copyright or in pharma law Discount codes available for IPKat readers interested in copyright or in pharma law Reviewed by Eleonora Rosati on Monday, October 29, 2018 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.